Maternal care for anti-D [Rh] antibodies, first trimester (fetus 1)
ICD-10 O36.0111 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, first trimester (fetus 1).
Maternal care for anti-D [Rh] antibodies is critical during the first trimester of pregnancy, particularly for the first fetus. This condition arises when an Rh-negative mother is exposed to Rh-positive blood, leading to the production of anti-D antibodies. These antibodies can cross the placenta and potentially cause hemolytic disease in the fetus, resulting in complications such as fetal growth restriction, fetal distress, and even fetal demise. Close monitoring of the fetus is essential, including regular ultrasounds to assess growth and well-being, as well as non-stress tests to evaluate fetal heart rate patterns. Maternal care may involve administering Rh immunoglobulin (RhoGAM) to prevent antibody formation and mitigate risks to the fetus. The management of this condition requires a multidisciplinary approach, including obstetricians and maternal-fetal medicine specialists, to ensure optimal outcomes for both mother and child.
Detailed records of maternal blood type, antibody screening results, and any interventions such as RhoGAM administration.
Routine prenatal visits, management of Rh incompatibility, and monitoring for fetal growth issues.
Ensure accurate tracking of fetal development and maternal health status.
Comprehensive assessments of fetal well-being, including ultrasound findings and non-stress test results.
High-risk pregnancies with Rh incompatibility, management of fetal growth restriction, and planning for delivery.
Focus on advanced monitoring techniques and potential interventions.
Used during initial prenatal visits to determine maternal blood type and Rh status.
Document the results of blood typing and any follow-up care.
Obstetricians should ensure that Rh status is monitored throughout pregnancy.
Anti-D antibodies can lead to serious complications for the fetus, including hemolytic disease. It is crucial to monitor the mother and fetus closely to manage any potential risks.
